Aminoguanidine produces beneficial haemodynamic effects in a canine model of acute pulmonary thromboembolism

Acta Physiologica

Volumn 191, Issue 3, 2007, Pages 189-196

  Dias Junior, C A C ^a   Sertorio, J T C ^a   Tanus Santos, J E ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Acute pulmonary embolism; Aminoguanidine; Cyclic GMP; L NAME; Nitric oxide; Nitric oxide synthase; Thromboembolism

Indexed keywords

AMINOGUANIDINE; CYCLIC GMP; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOPULMONARY HEMODYNAMICS; CARDIOVASCULAR RESPONSE; CHEMOLUMINESCENCE; CONTROLLED STUDY; DOG; ENZYME INDUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART PROTECTION; LUNG EMBOLISM; LUNG VASCULAR RESISTANCE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL;

ACUTE DISEASE; ANIMALS; BLOOD PRESSURE; CYCLIC GMP; DOGS; FEMALE; GUANIDINES; LUNG; MALE; MODELS, ANIMAL; NG-NITROARGININE METHYL ESTER; NITRATES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PULMONARY EMBOLISM; VASCULAR RESISTANCE;

EID: 35248815939     PISSN: 17481708     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1748-1716.2007.01746.x     Document Type: Article

References (42)

1. Agvald, P., Adding, L.C., Nilsson, K.F., Gustafsson, L.E. Linnarsson, D. 2006. Increased expired NO and roles of CO(2) and endogenous NO after venous gas embolism in rabbits. Eur J Appl Physiol 97, 210 215.
2. Barnes, P.J. Liu, S.F. 1995. Regulation of pulmonary vascular tone. Pharmacol Rev 47, 87 131.
3. Castro, M.M., Rizzi, E., Rascado, R.R., Nagassaki, S., Bendhack, L.M. Tanus-Santos, J.E. 2004. Atorvastatin enhances sildenafil-induced vasodilation through nitric oxide-mediated mechanisms. Eur J Pharmacol 498, 189 194.
4. Cooke, J.P. Dzau, V.J. 1997. Nitric oxide synthase: role in the genesis of vascular disease. Annu Rev Med 48, 489 509.
5. Dias-Junior, C.A. Tanus-Santos, J.E. 2006. Hemodynamic effects of sildenafil interaction with a nitric oxide donor compound in a dog model of acute pulmonary embolism. Life Sci 79, 469 474.
6. Dias-Junior, C.A., Souza-Costa, D.C., Zerbini, T., Rocha, J.B.T., Gerlach, R.F. Tanus-Santos, J.E. 2005a. Effect of sildenafil on pulmonary embolism-induced oxidative stress and pulmonary hypertension. Anesth Analg 101, 115 120.
7. Dias-Junior, C.A., Vieira, T.F., Moreno, H. Jr., Evora, P.R. Tanus-Santos, J.E. 2005b. Sildenafil selectively inhibits acute pulmonary embolism-induced pulmonary hypertension. Pulm Pharmacol Ther 18, 181 186.
8. Dias-Junior, C.A., Gladwin, M.T. Tanus-Santos, J.E. 2006. Low-dose intravenous nitrite improves hemodynamics in a canine model of acute pulmonary thromboembolism. Free Radic Biol Med 41, 1764 1770.
9. Emerson, M., Momi, S., Paul, W., Alberti, P.F., Page, C. Gresele, P. 1999. Endogenous nitric oxide acts as a natural antithrombotic agent in vivo by inhibiting platelet aggregation in the pulmonary vasculature. Thromb Haemost 81, 961 966.
10. Evgenov, O.V., Hevroy, O., Bremnes, K.E. Bjertnaes, L.J. 2000. Effect of aminoguanidine on lung fluid filtration after endotoxin in awake sheep. Am J Respir Crit Care Med 162, 465 470.
11. Faro, R., Tanus-Santos, J.E., Zappellini, A., Antunes, E. De Nucci, G. 1999. The role of heart rate in the modulation of the decreased cardiac output induced by acute nitric oxide synthesis inhibition in anaesthetized dogs. J Auton Pharmacol 19, 257 262.
12. Fortuna, G.M., Figueiredo-Lopes, L., Dias-Junior, C.A.C., Gerlach, R.F. Tanus-Santos, J.E. 2007. A role for matrix metalloproteinase-9 in the hemodynamic changes following acute pulmonary embolism. Int J Cardiol 114, 22 27.
13. Griffiths, M.J., Messent, M., MacAllister, R.J. Evans, T.W. 1993. Aminoguanidine selectively inhibits inducible nitric oxide synthase. Br J Pharmacol 110, 963 968.
14. Hampl, V. Herget, J. 2000. Role of nitric oxide in the pathogenesis of chronic pulmonary hypertension. Physiol Rev 80, 1337 1372.
15. Ignarro, L.J., Buga, G.M., Wood, K.S., Byrns, R.E. Chaudhuri, G. 1987. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 84, 9265 9269.
16. Layish, D.T. Tapson, V.F. 1997. Pharmacologic hemodynamic support in massive pulmonary embolism. Chest 111, 218 224.
17. Lee, J.H., Chun, Y.G., Lee, I.C. et al. 2001. Pathogenic role of endothelin 1 in hemodynamic dysfunction in experimental acute pulmonary thromboembolism. Am J Respir Crit Care Med 164, 1282 1287.
18. Mehta, S. 2005. The effects of nitric oxide in acute lung injury. Vascul Pharmacol 43, 390 403.
19. Metzger, I.F., Sertorio, J.T.C. Tanus-Santos, J.E. 2006. Relationship between systemic nitric oxide metabolites and cyclic GMP in healthy male volunteers. Acta Physiol 188, 123 127.
20. Nagassaki, S., Sertorio, J.T.C., Metzger, I.F., Bem, A.F., Rocha, J.B.T. Tanus-Santos, J.E. 2006. eNOS gene T-786C polymorphism modulates atorvastatin-induced increase in blood nitrite. Free Radic Biol Med 41, 1044 1049.
21. Nilsson, B.O. 1999. Biological effects of aminoguanidine: an update. Inflamm Res 48, 509 515.
22. Palei, A.C.T., Zaneti, R.A.G., Fortuna, G.M., Gerlach, R.F. Tanus-Santos, J.E. 2005. Hemodynamic benefits of matrix metalloproteinase-9 inhibition by doxycycline during experimental acute pulmonary embolism. Angiology 5, 611 617.
23. Palmer, R.M., Ferrige, A.G. Moncada, S. 1987. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327, 524 526.
24. Peng, X., Abdulnour, R.E., Sammani, S. et al. 2005. Inducible nitric oxide synthase contributes to ventilator-induced lung injury. Am J Respir Crit Care Med 172, 470 479.
25. Persson, M.G., Gustafsson, L.E., Wiklund, N.P., Moncada, S. Hedqvist, P. 1990. Endogenous nitric oxide as a probable modulator of pulmonary circulation and hypoxic pressor response in vivo. Acta Physiol Scand 140, 449 457.
26. Sadosty, A.T., Boie, E.T. Stead, L.G. 2003. Pulmonary embolism. Emerg Med Clin North Am 21, 363 384.
27. Sander, M., Welling, K.L., Ravn, J.B., Boberg, B. Amtorp, O. 2003. Endogenous NO does not regulate baseline pulmonary pressure, but reduces acute pulmonary hypertension in dogs. Acta Physiol Scand 178, 269 277.
28. Smulders, Y.M. 2000. Pathophysiology and treatment of haemodynamic instability in acute pulmonary embolism: the pivotal role of pulmonary vasoconstriction. Cardiovasc Res 48, 23 33.
29. Souza-Costa, D.C., Zerbini, T., Metzger, I.F., Rocha, J.B., Gerlach, R.F. Tanus-Santos, J.E. 2005a. l-Arginine attenuates acute pulmonary embolism-induced oxidative stress and pulmonary hypertension. Nitric Oxide 12, 9 14.
30. Souza-Costa, D.C., Zerbini, T., Palei, A.C., Gerlach, R.F. Tanus-Santos, J.E. 2005b. L-arginine attenuates acute pulmonary embolism-induced increases in lung matrix metalloproteinase-2 and matrix metalloproteinase-9. Chest, 128, 3705 3710.
31. Souza-Silva, A.R., Dias-Junior, C.A., Uzuelli, J.A., Moreno, H. Jr., Evora, P.R. Tanus-Santos, J.E. 2005. Hemodynamic effects of combined sildenafil and l-arginine during acute pulmonary embolism-induced pulmonary hypertension. Eur J Pharmacol 524, 126 131.
32. Stamler, J.S., Loh, E., Roddy, M.A., Currie, K.E. Creager, M.A. 1994. Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. Circulation 89, 2035 2040.
33. Szabo, C., Ferrer-Sueta, G., Zingarelli, B., Southan, G.J., Salzman, A.L. Radi, R. 1997. Mercaptoethylguanidine and guanidine inhibitors of nitric-oxide synthase react with peroxynitrite and protect against peroxynitrite-induced oxidative damage. J Biol Chem 272, 9030 9036.
34. Tanus-Santos, J.E. Theodorakis, M.J. 2002. Is there a place for inhaled nitric oxide in the therapy of acute pulmonary embolism? Am J Respir Med 1, 167 176.
35. Tanus-Santos, J.E., Moreno, H. Jr., Moreno, R.A., Martins, M.L., Pereira, R. de Nucci, G. 1999a. Inhaled nitric oxide improves hemodynamics during a venous air infusion (VAI) in dogs. Intensive Care Med 25, 983 989.
36. Tanus-Santos, J.E., Moreno, H. Jr., Zappellini, A. de Nucci, G. 1999b. Small-dose inhaled nitric oxide attenuates hemodynamic changes after pulmonary air embolism in dogs. Anesth Analg 88, 1025 1029.
37. Tanus-Santos, J.E., Gordo, W.M., Cittadino, M. Moreno, H. Jr. 2000. Plasma cGMP levels in air embolism-induced acute lung injury. J Crit Care 15, 137 141.
38. Waldman, S.A. Murad, F. 1987. Cyclic GMP synthesis and function. Pharmacol Rev 39, 163 196.
39. Wilson, P.S., Thompson, W.J., Moore, T.M., Khimenko, P.L. Taylor, A.E. 1997. Vasoconstriction increases pulmonary nitric oxide synthesis and circulating cyclic GMP. J Surg Res 70, 75 83.
40. Wood, K.E. 2002. Major pulmonary embolism: review of a pathophysiologic approach to the golden hour of hemodynamically significant pulmonary embolism. Chest 121, 877 905.
41. Xia, Y. Zweier, J.L. 1997. Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages. Proc Natl Acad Sci USA 94, 6954 6958.
42. Zappellini, A., Teixeira, S.A., Muscara, M.N., Zatz, R., Antunes, E. De Nucci, G. 1996. In vivo inhibition of nitric oxide synthesis does not depend on renin-angiotensin system activation. Eur J Pharmacol 317, 285 291.